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ABSTRACT
In the present study, genotype–phenotype correlations in
eight Dutch DFNB8/10 families with compound hetero-
zygous mutations in TMPRSS3 were addressed. We
compared the phenotypes of the families by focusing on
the mutation data. The compound heterozygous variants
in the TMPRSS3 gene in the present families included one
novel variant, p.Val199Met, and four previously described
p a t h o g e n i cv a r i a n t s ,p . A l a 3 0 6 T h r ,p . T h r 7 0 f s ,p . A l a 1 3 8 G l u ,
and p.Cys107Xfs. In addition, the p.Ala426Thr variant,
which had previously been reported as a possible poly-
morphism, was found in one family. All affected family
members reported progressive bilateral hearing impair-
ment, with variable onset ages and progression rates. In
general, the hearing impairment affected the high
frequencies first, and sooner or later, depending on the
mutation,the low frequencies started todeteriorate, which
eventually resulted in a flat audiogram configuration. The
ski-slope audiogram configuration is suggestive for the
involvement of TMPRSS3. Our data suggest that not only
the protein truncating mutation p.T70fs has a severe effect
but also the amino acid substitutions p.Ala306Thr and p.
Val199Met. A combination of two of these three mutations
causes prelingual profound hearing impairment. How-
ever, in combination with the p.Ala426Thr or p.Ala138Glu
mutations, a milder phenotype with postlingual onset of
the hearing impairment is seen. Therefore, the latter
mutations are likely to be less detrimental for protein
function. Further studies are needed to distinguish
possible phenotypic differences between different
TMPRSS3 mutations. Evaluation of performance of
patients with a cochlear implant indicated that this is a
good treatment option for patients with TMPRSS3 muta-
tions as satisfactory speech reception was reached after
implantation.
Keywords: DFNB8/10, TMPRSS3 mutations,
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Autosomal recessive nonsyndromic hearing impair-
ment (arNSHI) is the most common type of inherited
hearing impairment, accounting for approximately
80% of inherited prelingual hearing impairment. The
phenotype associated with nonsyndromic recessive
hearing impairment is usually prelingual, non-pro-
gressive, and severe to profound. Autosomal recessive
inheritance is rare in nonsyndromic hearing impair-
ment with postlingual onset (Petersen and Willems
2006).
Already 72 loci have been described to be
involved in arNSHI and 40 causative genes have
been indentified thus far, indicating enormous
genetic heterogeneity. However, there is little knowl-
edge about the contribution of the different genes
to arNSHI in the European population. GJB2
mutations are a frequent cause of arNSHI, as in
most populations; however, the relative contribution
varies per country. Other genes reported to be
relatively important for arNSHI in populations of
w e s t e r nE u r o p e a no r i g i na r eTMC1, OTOF,a n d
CDH23 (Hilgert et al. 2009).
M u t a t i o n si nt h et r a n s m e m b r a n ep r o t e a s es e r i n e
3( TMPRSS3, OMIM 605511) gene on chromosome
21q22 are responsible not only for arNSHI with a
prelingual onset (DFNB10, OMIM 605316; Bonne-
Tamir et al. 1996) but also for postlingual (DFNB8,
OMIM 601072; Veske et al. 1996)a r N S H I .
TMPRSS3 m R N Ah a sb e e nd e t e c t e di nt h es p i r a l
ganglion, the entire epithelium that supports the
cells of the organ of Corti, and in low levels in the
stria vascularis, but was not detected in sensory
hair cells with in situ hybridization (Guipponi et al.
2002). However, in a more recent study by
Guipponi et al. (2008), expression of the TMPRSS3
protein was shown in the inner hair cells of the
organ of Corti and in the cell bodies of the spiral
ganglion neurons. The function of TMPRSS3 in
the auditory pathway is currently poorly under-
stood, but it has been hypothesized that lack of
TMPRSS3 activity results in hearing impairment
because of an increased sodium concentration in
the endolymph by insufficient ENaC activation
(Guipponi et al. 2002). However, individuals with
pseudohypoaldosteronism type 1, which are homo-
zygous for null alleles of ENaC subunits, demon-
strate no hearing impairment (Peters et al. 2006).
This indicates that hearing impairment associated
with TMPRSS3 mutations cannot be explained by
inactive ENaC. Involvement of TMPRSS3 in the
proteolytic cleavage of proneurotrophins could
play a role (Guipponi et al. 2002). Proneurotro-
phins function in the development and mainte-
nance of inner ear innervation (Farinas et al.
2001). The serine protease plasmin, which belongs
to the same family as TMPRSS3, has been shown to
cleave the neurotrophic factor BDNF (Bom et al.
2001; Guipponi et al. 2002).
So far, mutations in TMPRSS3 have mainly been
identified in families from Asian and Mediterranean
countries, and did not seem to contribute substan-
tially to prelingual arNSHI in the Caucasian pop-
ulation (Wattenhofer et al. 2002). However, in the
present study, we demonstrate that mutations in
TMPRSS3 are a common cause of progressive
arNSHI with a childhood onset in the Dutch
population. We characterized the hearing impairment
in eight Dutch families with compound heterozygous
mutations in TMPRSS3 and describe genotype–
phenotype correlations. The present family E was
previously described as family 2 in a report on
autosomal recessive progressive high-frequency
hearing impairment with childhood onset (Cremers
et al. 1987).
METHODS
Patients
The pedigrees of eight families with arNSHI were
constructed (Fig. 1;C r e m e r se ta l .1987). After
informed consent had been obtained from the
participating family members, audiograms were
obtained to establish the hearing impairment pheno-
type of these families. The study was approved by the
medical ethics committee of the Radboud University
Nijmegen Medical Centre.
Examination of the family members included a
medical history guided by a questionnaire, otoscopy,
pure tone audiometry, and drawing blood samples for
DNA isolation. Some of the affected family members
underwent speech audiometry, vestibulo-ocular
examination, and high-resolution spiral computed
tomography imaging of the temporal bones. Further-
more, concomitant disease, use of medication, and
any other possible causes of acquired hearing impair-
ment were ruled out. Previous medical records and
audiograms were traced for individual longitudinal
analysis. The previously published audiograms of
family E were also included (Cremers et al. 1987).
Linkage analysis
Genomic DNA of all participating individuals was
extracted from peripheral blood lymphocytes
according to standard protocols. Families D and E
were selected for linkage analysis. For family D, the
unaffected parents and three affected and five
unaffected siblings were genotyped using the Illu-
mina 6k single nucleotide polymorphism (SNP)
754 WEEGERINK ET AL.: Mutations in the TMPRSS3 Genearray according to the manufacturer’sp r o t o c o l .
Similarly, for family E, the unaffected mother and
four affected and five unaffected siblings were
genotyped. Multipoint linkage analysis was per-
formed with GeneHunter version 2.1r5 in the Easy-
Linkage software package (Hoffmann and Lindner
2005). An autosomal recessive mode of inheritance
with a penetrance of 95% and a disease allele
frequency of 0.001 were used for limit of detection
(LOD) score calculations.
FIG. 1. Pedigrees of the Dutch families with autosomal recessive hearing impairment and segregation of the TMPRSS3 mutations. Family E is
previously described by Cremers et al. (1987). All unaffected sibs were either carrier of one mutant allele or of two wild-type alleles. Square,
male; circle, female; open symbol, clinically unaffected; solid symbol, clinically affected; slash, deceased individuals. NT not tested.
WEEGERINK ET AL.: Mutations in the TMPRSS3 Gene 755Sequence analysis and prediction of effects
of mutations on protein structure
Amplification of all coding exons and flanking
intronic sequences by PCR was performed on 40 ng
of genomic DNA with Taq DNA polymerase (Roche).
Primer sequences and PCR conditions are available in
Electronic supplementary material (ESM) Table 1.
PCR fragments were purified using NucleoFast 96
PCR plates (Clontech) according to the manufac-
turer’s protocol. Sequence analysis was performed
with the ABI PRISM Big Dye Terminator Cycle
Sequencing V3.1 Ready Reaction kit and the ABI
PRISM 3730 DNA analyzer (Applied Biosystems).
For segregation analysis of the identified TMPRSS3
mutations in the families, restriction digestion could be
performed. Relevant exons were amplified and PCR
products were purified as described for sequencing.
Digestion of the PCR products with restriction enzymes
was performed according to the manufacturer’s proto-
col, and restriction fragments were analyzed on 2%
agarose gels. Primer sequences and restriction enzymes
are listed in ESM Table 1. The same approach was used
for testing the occurrence of the c.595G9Aa n d
c.1276G9A variants in Dutch control individuals. As
reference sequence, NM_024022 was used.
The effects of the amino acid substitutions in
TMPRSS3 on its structure were analyzed using the
Project HOPE web server (http://www.cmbi.ru.nl/
hope; Venselaar et al. 2010). The exact 3D structure
of TMPRSS3 is unknown; therefore, HOPE built a
model based on the homologous structure protein
data bank entry 1z8g (Herter et al. 2005). The model
was built using an automatic script in the Yasara and
WHAT IF Twinset (Vriend 1990; Krieger et al. 2002).
Audiometry and data analysis
Audiometric examination comprised conventional
pure tone audiometry in a sound-treated room. Air
conduction (AC) thresholds were measured in deci-
bel hearing level (HL) at 0.25, 0.5, 1, 2, 4, and 8 kHz;
bone conduction thresholds were measured in deci-
bel HL at 0.5, 1, 2, 4, and 8 kHz. The individual 95th
percentile threshold values of presbyacusis in relation
to the patient’s sex and age were derived for each
frequency using the ISO 7029 method. Individuals
were considered affected if the best hearing ear
showed thresholds beyond the 95th percentile thresh-
old values for presbyacusis at three frequencies or
more. Binaural mean air conduction threshold values
were calculated for each frequency.
Individual longitudinal regression analysis of bin-
aural mean air conduction threshold values on age
was performed for individual 10 of family E because
the audiometric data of this individual were most
comprehensive (Cremers et al. 1987). The regression
coefficient (slope) was called annual threshold dete-
rioration (ATD), expressed in decibels per year.
Progression was significant if the 95% confidence
interval of the ATD did not include zero.
Speech audiometry was performed under the afore-
mentioned conditions using standard Dutch monosyl-
labic consonant–vocal–consonant word lists. The
maximum phoneme recognition score (mean percent-
age correct for both ears) was retained from the
monaural performance versus intensity curves. These
maximum phoneme recognition scores were analyzed
in relation to age and to pure tone average (mean value
for both ears) at frequencies of 1, 2, and 4 kHz
(PTA1,2,4 kHz). Cross-sectional analysis was performed
using linear regression analysis to determine the local
average slope, called deterioration rate, in the score-
against-age plot and deterioration gradient in the score-
against-PTA1,2,4 kHzplot.Apreviouslydescribedgroupof
subjectswithonlypresbyacusiswasusedasthereference
group (De Leenheer et al. 2002).
Vestibulo-ocular examination and data analysis
Nine of 16 affected individuals (A5, B3, C4, E8, E9,
E10, E13, and G3) underwent vestibular and ocular
motor tests. The test included evaluation of the
vestibulo-ocular reflex using electronystagmography
with computer analysis and saccadic, smooth pursuit,
and optokinetic nystagmus responses. Vestibular stim-
ulation comprised rotatory and caloric tests. Details
and normal values have been described previously
(Kunst et al. 2000).
Genotype–phenotype correlations
We compared the phenotype of the present families
by focusing on the genotype to study whether the
mutations differ in severity. The phenotypes of the
different families were compared when at least one
identical mutation in TMPRSS3 was present. There-
fore, the effect of the second mutation on the
phenotype in these families could be determined.
All family members with the same compound hetero-
zygous mutations were taken together, for example,
families A/G and D/F. The threshold values of each
family member were compared to the threshold
values of every family member of the other family.
We compared the thresholds at all frequencies in
relation to age.
Evaluation of the effect of CI on phoneme
recognition
Nine patients underwent cochlear implantation (CI).
Speech audiometry was performed in a quiet environ-
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WEEGERINK ET AL.: Mutations in the TMPRSS3 Gene 757ment using standard monosyllabic Dutch word lists
after cochlear implantation. Words were presented
through a loudspeaker at a fixed distance of 1 m from
the patient at a normal conversational level of 70 dB
sound pressure level (SPL). Subject responses were
scored as the percentage of phonemes correct. As a
reference, the test results after 1 year of use in
postlingually implanted adults were used. The first
reference group (n=70) was implanted with a CII/
HR90K device of Advanced Bionics® and the second
reference group (n=65) with a Nucleus 24RCA of
Cochlear®. A mean phoneme score of 64% (SD 23%)
was demonstrated in the first reference group, and
the second group (n=65) showed a mean phoneme
score of 72% (SD 18%; Verhaegen et al. 2008).
RESULTS
Compound heterozygous TMPRSS3 mutations
in Dutch arNSHI patients
Linkage analysis was performed for two arNSHI
families, D and E, with progressive hearing impair-
ment. For family D, five regions were found with a
maximum LOD score of ~1.82 (ESM Fig. 1). Two of
the regions contained a known deafness gene,
namely, GRXCR1 on chromosome 4 and TMPRSS3
on chromosome 21. Mutations in GRXCR1 were
excluded in a previous study (Schraders et al. 2010).
For family E, three regions with suggestive linkage
were found with a LOD score of ~2.42. One of those
regions harbored TMPRSS3. In both families, the
LOD score for the TMPRSS3 region reached the
theoretical maximum LOD score.
Thus, mutation analysis was performed for all
coding exons and exon–intron boundaries of
TMPRSS3. In both families, compound heterozygous
sequence variants were detected (Table 1). The
variants c.413C9A, c.916G9A, and c.207delC have
been described before to be pathogenic in families
with arNSHI. The c.1276G9A variant is present in the
SNP database (http://www.ncbi.nlm.nih.gov/sites/
SNP; rs56264519). However, this SNP has not been
validated. We did not identify this variant in 590
Dutch control alleles, and, importantly, the resulting
amino acid change Ala426Thr has been shown to
affect protein function (Lee et al. 2003). We therefore
considered the Ala426Thr substitution to be patho-
genic. All four TMPRSS3 mutations co-segregated with
the hearing impairment in the families (Fig. 1).
To investigate the contribution of TMPRSS3 muta-
tions in progressive hearing impairment, we screened
a panel of 22 unrelated supposed arNSHI patients
with progressive hearing impairment; compound
heterozygous mutations were found in four of them,
belonging to families A, B, C, and F (Fig. 1 and
Table 1). The novel variant, c.595G9A, leading to the
substitution of a methionine for a valine at position
199 of the protein (p.Val199Met) was present in two
patients. This variant was not found in 590 Dutch
control alleles. In summary, we identified compound
heterozygous TMPRSS3 mutations in 6 of 24 families
(25%) with progressive arNSHI.
To evaluate the prevalence of TMPRSS3 mutations
in unselected patients with (putative) arNSHI in the
Netherlands, we screened a panel of 212 index
patients for whom GJB2 mutations had been excluded
as the cause of their hearing impairment. Compound
heterozygous mutations were detected in two of these
index patients (Table 1), which segregated with the
hearing impairment in the corresponding families G
and H (Fig. 1). Hearing impairment was found to be
progressive in these families as well.
Large variation in age of onset
The clinical characteristics and genotypes of the
patients are listed in Table 1. For none of the affected
family members, there was evidence of other causes of
hearing impairment, and otoscopy was normal. All
affected individuals reported progressive bilateral
hearing impairment. Some individuals had prelingual
hearing impairment, whereas other individuals were
not aware of being hearing impaired until in their late
teens, which indicates postlingual hearing impairment
(Table 1).
Imaging of temporal bones
Computed tomography (CT) of the temporal bone
was performed in ten individuals (A5, C4, D4, E8, E9,
E10, E13, F3, G3, and H3), mainly as part of a
preoperative CI selection procedure. Magnetic reso-
nance imaging (MRI) was accomplished in individual
B3. The CT scans and MRI showed normal middle
and inner ear structures in all cases.
Vestibulo-ocular examination
Although vestibular symptoms were not reported,
testing of vestibular function in three affected indi-
viduals (A5, E8, and E9) revealed mild hyperreflexia
of the velocity step responses with time constants
between 28 and 32 s (normal limit, 26 s). Further-
more, individuals G3 and H3 showed significant
hyporeflexia of the velocity step responses with time
constants between 3 and 9 s for both nystagmus
directions. Caloric tests revealed borderline bilateral
caloric weakness in individual G3 and normal caloric
functioning in individual H3. None of the relative
prevalences of the abnormal vestibular findings was
above chance level. The tests of vestibular function in
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E13) demonstrated no abnormalities. The vestibulo-
ocular examination in all nine affected individuals was
performed before cochlear implantation. None of the
patients reported by Bonne-Tamir et al. (1996)
showed signs of vestibular involvement. However,
formal vestibular tests were not performed. Informa-
tion on the vestibular function of the other TMPRRS3
families previously reported were not available.
Typical ski-slope audiogram configuration
A representative selection of the available pure tone
audiograms of all 16 affected individuals are shown in
Figure 2. The thresholds in families B and C (gray
audiograms in Fig. 2) are higher than or similar to the
thresholds in the other families, at a much younger
age. This is in accordance with the reported prelin-
gual hearing impairment in these families. Most
frequently, a down-sloping audiogram configuration
was observed, indicating high-frequency hearing
impairment. Remarkable is the typical ski-slope audio-
gram configuration for patients with postlingual
hearing impairment, as seen in, for example, individ-
uals A5, F3, D6, and H3. However, flatter audiogram
configurations, close to residual hearing, were also
observed (individuals D4, E8, E9, E10, E13, and G3),
but only at ages above 28 years. The families with
postlingual hearing impairment initially presented
with hearing impairment of the high frequencies
which was followed by an increase of the low- and
mid-frequency threshold values with advancing age.
FIG. 2. Selection of binaural mean air conduction threshold values of clinically affected family members at different ages, ordered by age (from
top left to bottom right) at last visit (Cremers et al. 1987). Family number and sequence number are above each audiogram. Gray background,
relatively poorer thresholds.
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high at the low and mid-frequencies at ages between
21 and 28 years as compared with the thresholds of
individuals D6 and D9. The threshold of individual G3
at these frequencies are also remarkably high in
comparison to the thresholds of individuals G4 and
G7 at the same ages. So far, there is less variation in
thresholds in families E and H at matching ages.
However, it is not clear at this point whether the
hearing impairment in individual H4 will show the
same progression as the hearing impairment of his
brother H3 until the age of 29 years.
Progressive bilateral hearing impairment at all
frequencies
Regression analysis for individual E10 demonstrated a
significant deterioration of threshold levels with
advancing age for all frequencies. The longitudinal
threshold data of individual E10 covered approxi-
mately 36 years (from age 9 to 45 years). Figure 3a
shows the threshold data for all frequencies sepa-
rately. A nonlinear regression model of a dose–
response curve with a variable slope fitted far better
to the data than a linear regression model (compara-
tive data not shown); the fitted curves are included in
Figure 3a. The maximum local slope (ATD) was about
6 dB/year at 0.25 kHz at ages between 25 and 35 years.
This maximum ATD can also be derived from the age-
related typical audiogram (ARTA; Fig. 3b); the thresh-
old at 0.25 kHz increases from about 40 dB at 25 years
to about 95 dB at 35 years. Figure 3 illustrates that
most of the progression at the higher frequencies, in
the absence of a pronounced congenital hearing
impairment, already occurred before the age of
10 years. If that indeed was the case in individual
E10, the threshold levels at around 9 years of age
would suggest an average progression of about 10 dB/
year at 2–8 kHz.
Figure 3a also shows all the longitudinal threshold
data of individuals A5, D4, D6, D7, E8, E9, E13, F3,
G3, H3, and H5 (postlingual DFNB8 patients; see
below). The available audiograms of individual A5
were measured between 6 and 13 years of age. The
hearing impairment in this individual indeed demon-
strated progression only at 2–8 kHz, which is on the
order of about 10 dB/year. Figure 3a also demon-
strates that the longitudinal data for individual E10
are, more or less, representative for the whole group
o fD F N B 8p a t i e n t si nt h ep r e s e n tc o l l e c t i o no f
families. The sigmoidal regression curve for individual
E10 takes a fairly median position; however, some of
the other individuals are represented by threshold
values that indicate major deviations from that
position (Fig. 3a).
Relatively good speech recognition scores
Figure 4 shows the available single-snapshot measure-
ments of the phoneme scores in the affected mem-
bers of families A, D, E, F, G, and H. For the more
severely affected families B and C (see below), we only
had one score for individual C4. Speech recognition
in the patients with a TMPRSS3 mutation was severely
impaired, even at young ages. The 50% score was
attained at the age of 25 years, whereas in the
presbyacusis group, this score was attained at 89 years.
At approximately 55 years of age, there was no
remaining speech recognition. The PTA1,2,4 kHz levels
at which speech recognition scores of 50% were
attained in the TMPRSS3 and the presbyacusis
patients were 95 and 87 dB, respectively. Therefore,
the TMPRSS3 patients tended to have somewhat
higher scores than the presbyacusis patients at similar
PTA1,2,4 kHz levels. The deterioration rate in the score-
against-age plot was 1.6% per year, and the deterio-
ration gradient in the score-against-PTA1,2,4 kHz plot
was 2.1% per decibel. The presbyacusis group showed
a higher deterioration rate (3.3% per year) and a
lower deterioration gradient (1.1% per decibel).
Compared with matching scores of the other family
members, the speech recognition score of individual
C4 was observed at a younger age and a higher
PTA1,2,4 kHz level (Fig. 4). Unfortunately, speech
recognition scores were not reported for previously
described families with TMPRSS3 mutations.
Genotype–phenotype correlations
In the present eight families, four different missense
mutations and two frameshift mutations were
detected. Four of these mutations were recurrent
and present in two to four of the eight families. To
study whether the mutations differ in severity, we
compared the phenotypes of the families with one
identical mutation in TMRPSS3. This allows a compar-
ison of the effect of the second mutation in these
families. For example, patients in families B and E
have the p.Thr70fs mutation in common (Table 1);
therefore, a comparison of the phenotypic effect of
the p.Ala306Thr mutation in family B and the p.
Ala426Thr mutation in family E is possible. Thresh-
FIG. 3. a Longitudinal individual measurements of individuals A5,
D4, D6, D7, E8, E9, E10, E13, F3, G3, H3, and H5 for each
frequency separately (different symbols for each individual; Cremers
et al. 1987). A dose–response curve with a variable slope could be
obtained for the longitudinal data of individual E10 for each
frequency (bold line). b ARTA derived from a longitudinal regression
analysis of mean AC threshold levels of individual E10. Italics
indicate age in years.
b
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in family E at ages between 9 and 30 years, but fairly
similar to those in family E at age 24–37 years and
better than those in family E at age 36–49 years
(Fig. 2). This implies that threshold levels similar to
those shown by family B in the first decade of life are
unlikely to be found in family E before the third or
fourth decade of life and that poorer levels are only
likely to be found in family E from the fourth to the
fifth decade of life onwards. This suggests that the p.
Ala426Thr mutation has a milder effect than the p.
Ala306Thr mutation. The same procedure was
repeated for the other mutations. The p.Ala306Thr
mutation has a fairly similar phenotypic effect as p.
Val199Met (families A/G versus D/F) and p.Cys107fs
(families D/F versus family H), whereas p.Val199Met
has a fairly similar effect as p.Thr70fs (family B versus
C) and p.Cys107fs (families A/G versus family H): this
suggests that also p.Ala306Thr and p.Thr70fs must
have fairly similar phenotypic effects. Both p.
Ala426Thr and p.Ala138Glu have milder phenotypic
effects than p.Ala306Thr (family B versus E and family
C versus families A/G, respectively); this suggests that
p.Ala426Thr and p.Ala138Glu have fairly similar
phenotypic effects. Furthermore, p.Ala138Glu has a
milder effect than p.Val199Met (family C versus
families D/F) and also a milder effect than p.Thr70fs
(family B versus families D/F). The thresholds of
individuals D4 and G3 were higher compared with the
thresholds of their sibs, and therefore individuals D4
and G3 were excluded from the genotype–phenotype
assessment. Nevertheless, the classification of muta-
tions did not change when individuals D4 and G3
were included. In line with these considerations and
the levels of the thresholds in the various families, we
suggest that the mutations in TMPRSS3 can be
classified in mild and severe mutations. Our classi-
fication of TMPRSS3 mutations is in accordance with
the two types of hearing impairment phenotypes:
1. DFNB10: a severe congenital or early childhood
type with prelingual hearing impairment (families
B and C) caused by the presence of two severe
mutations
2. DFNB8: a later-onset progressive but initially
milder type with postlingual hearing impairment
(families A/G, D/F, and E) caused by the presence
of one mild and one severe mutation
Predicted effects of amino acid substitutions on
TMPRSS3 structure
Genotype–phenotype correlations in the present study
suggest that the amino acid substitutions p.Ala138Glu
and p.Ala426Thr have a less severe effect as compared
with p.Val199Met and p.Ala306Thr. Both substitutions
p.Ala306Thr and p.Ala426Thr are within the serine
protease domain. These changes result in the substitu-
tion of a larger residue for a conserved amino acid,
predicted to result in the destabilization of the protein.
The difference in severity of the effect of the two
mutationsmightwellbeexplainedbythelocationofthe
substituted residue. The p.Ala306Thr is located close to
one of the active residues, Asp304, and therefore this
substitution can be predicted to directly disturb the
function of the serine protease domain. Moreover, the
alanine at position 426 is predicted to be semi-buried in
the protein, and the side chain of threonine is only
slightly bigger than the alanine side chain. Therefore,
there could be enough space for the side chain of the
threonine atthis position(Fig. 5a). Bothsubstitutions p.
Ala138Glu and p.Val199Met occur within the scavenger
receptorcysteine-rich(SRCR)domain,whichisthought
to be involved in interactions with extracellular mole-
FIG. 4. Single-snapshot measurements of the affected family
members of binaural mean phoneme recognition scores against age
(left) and against binaural mean pure tone average at 1, 2, and 4 kHz
(right; Cremers et al. 1987). The solid regression line covers the cross-
sectional analysis. The dotted curve represents presbyacusis and was
previously established for patients with presbyacusis. See text for the
meaning of the figures and the straight horizontal and vertical lines.
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conserved residues and substitute a larger amino acid
for the wild-type residue, which is predicted to cause
steric clashes with other residues and hence to destabi-
lize the protein (Fig. 5b). The 3D modeling could not
directly explain the difference in the effect of p.
Ala138Glu and p.Val199Met mutations since the exact
function and binding partners of the SRCR domain are
still unknown.
Good speech reception after cochlear
implantation
Eight family members underwent cochlear implanta-
tion in our hospital. Implantation was uneventful and
the implant was fully inserted on the left side in all
cases. Individuals B3, C4, and H3 were implanted with
a Nucleus Freedom (Cochlear), individuals E8 and G3
with a Nucleus Contour CI24R (Cochlear), and
individuals E9, E10 and E13 with a Clarion AB-
5100H (Advanced Bionics). Individual 4 of family D
was implanted in another hospital with a Nucleus
CI24M (Cochlear), and complete insertion was
reported. Phoneme and word scores were unavailable
for individuals D4 and H3. Individual H3 was
implanted less than a year ago. The available pho-
neme and word scores of sound presented at 70 dB
SPL 1 year after activation of the speech processor are
presented in Table 2. We compared these results with
the results of our two reference groups 12 months
after use. The phoneme and word scores in the seven
patients were above the average phoneme and word
scores of our two reference groups. The mean
phoneme score of 84.1% (SD=5.4) is significantly
higher than the phoneme score of reference group 1
(pG0.0001) and reference group 2 (p=0.0005).
Elbracht et al. (2007) also reported good results with
bilateral cochlear implantation, but unfortunately,
there were no phoneme or word scores available to
compare with our results.
DISCUSSION
This report presents the clinical and genetic analyses
of eight Dutch DFNB8/10 families with compound
heterozygous mutations in TMPRSS3 (Table 1). Our
study suggests genotype–phenotype correlations for
the detected mutations.
The reported age of onset and severity of hearing
impairment in the present families showed a wide
variation. Also within the families, variation was seen.
This is frequently demonstrated in hereditary hearing
impairment, however mainly in the dominantly
inherited forms. At a young age, TMPRSS3-associated
hearing impairment was more pronounced at the
high frequencies, and sooner or later, depending on
the mutation, thresholds for the low frequencies
deteriorated, eventually resulting in a flatter audio-
TABLE 2
Available phoneme and word scores preoperative and 1 year
after the activation of the speech processor of the cochlear
implant
Individual
Preoperative Postoperative
Phoneme score
(%)
Phoneme score
(%)
Word score
(%)
B3 – 91 –
C4 – 80 –
D4 5 ––
E8 20 89 75
E9 5 76 60
E10 0 82 58
E13 0 83 62
G3 2.5 88 68
H3 10 ––
Sound was presented at 70 dB sound pressure level
FIG. 5. Molecular modeling for TMPRSS3 missense mutations.
Graphic representation of the effect of the p.Ala306Thr and p.
Ala426Thr mutations in the serine protease domain (A) and of the p.
Ala138Glu and p.Val199Met in the SRCR domain (B). The wild-type
residues are depicted in green, while the mutant residues are shown
in red. The yellow structure represents a substrate for the serine
protease domain (figure made using the model for TMPRSS and
YASARA).
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as well as postlingual hearing impairments were
reported. A ski-slope audiogram configuration was
indicative for postlingual hearing impairment.
Twenty-two families with a mutation in TMPRSS3 had
been reported previously (Shahin et al. 2010;B o n n e -
Tamir et al. 1996; Veske et al. 1996; Ben-Yosef et al. 2001;
Masmoudi et al. 2001; Wattenhofer et al. 2002, 2005;
Ahmedetal.2004;Hutchinetal.2005;Walshetal.2006;
Elbracht et al. 2007; Table 3). Since the clinical data
provided for most of these TMPRSS3 families are very
limited, a thorough comparison with our data is not
possible. However, the available clinical data seem to be
in line with those of the present families. All families
with the TMPRSS3 mutations described in the literature
showed either severe to profound prelingual (DFNB10)
or postlingual (DFNB8) progressive bilateral sensor-
ineural hearing impairment (Shahin et al. 2010;B o n n e -
Tamir et al. 1996; Veske et al. 1996; Ben-Yosef et al. 2001;
Masmoudi et al. 2001; Wattenhofer et al. 2002, 2005;
Ahmed et al. 2004; Hutchin et al. 2005; Elbracht et al.
2007).
In the homozygous state, the previously described
TMPRSS3 mutations lead to either postlingual pro-
gressive (DFNB8) or prelingual severe to profound
(DFNB10) hearing impairment (Table 3), with one
exception, namely the p.Pro404Leu mutation
(Masmoudi et al. 2001; Wattenhofer et al. 2005).
Although Wattenhofer et al. (2005)d e s c r i b e da n
age of detection of hearing impairment of 6–7y e a r s
in a family with a homozygous p.Pro404Leu muta-
tion, the average threshold levels (0.5–4k H )a tt h a t
age were already 85–99 dB. Since members of this
family were reported to have had a normal hearing
until the age of detection, it can be concluded that
hearing impairment in this family exhibited a very
fast progression in childhood. Wattenhofer et al.
(2005) did not report on the speech development
TABLE 3
Overview of the literature on mutations in the TMPRRS3 gene
The gray rows represent families with postlingual hearing impairment (DFNB8) and the blank rows the families with prelingual hearing impairment (DFNB10).
Mutations in bold are the mutations with a mild effect on the phenotype, and mutations in italic are the mutations with a more severe effect on the phenotype
aThis is the notation of the IVS4-6G9A mutation with NP_076927.1 as a reference sequence
bThis is the notation of the IVS8+8insT mutation with NM_024022 as a reference sequence; the precise effect of this mutant allele is unknown
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ment might still be classified as prelingual, which is
defined as a delayed speech development. Hearing
impairment in the second family with a homozygous
p.Pro404Leu mutation was reported to be congen-
ital and severe to profound and therefore probably
prelingual (Masmoudi et al. 2001). Based on these
data, we conclude that p.Pro404Leu is likely to be a
severe mutation. Modifying genetic factors may
explain the difference in onset between the two
families with this mutation.
Both in the present and previously described
families, the severe classified mutations p.Ala306Thr,
p.Val199Met, and p.Thr70fs result in postlingual
hearing impairment when present in combination
with mutations only described to be associated with
postlingual hearing impairment (p.Arg216Cys, p.
Ala138Glu, and p.Ala426Thr mutations). Prelingual
hearing impairment is seen by us and others when the
Ala306Thr, Val199Met, and Thr70fs mutations are
present in the compound heterozygous state with
other mutations associated with prelingual hearing
impairment (p.Thr70fs and p.Ala306Thr). However,
there is an inconsistency in this classification of the
c.323-6G9A (p.Cys107fs) mutation. According to our
classification, the c.323-6G9A mutation is (relatively)
severe, which means that a homozygous c.323-6G9A
mutation could be expected to result in prelingual
(DFNB10) hearing impairment. However, a homozy-
gous c.323-6G9A mutation has been described to be
the underlying cause of postlingual (DFNB8) hearing
impairment by Veske et al. (1996). When the Berkeley
Drosophila Genome Project Splice Site Prediction
Program (http://www.fruitfly.org/seq_tools/splice.
html) was used, the c.323G9A mutation is predicted
to introduce a novel splice acceptor site with a score
of 0.96 (on a scale from 0 to 1) in addition to the
normal splice acceptor site (score of 0.94). Therefore,
both normal and abnormal splicing may occur in
relative amounts of transcripts that vary between
individuals, which may then lead to phenotypic
variation. Testing this hypothesis on patient samples
is not possible since the level of transcription of
TMPRSS3 is low in blood cells.
We can conclude that our study, combined with
previous data, suggests the classification of TMPRSS3
mutations into relatively mild and severe, which are
associated with DFNB8 (postlingual hearing impair-
ment) or DFNB10 (prelingual hearing impairment),
respectively. Furthermore, our study suggests that com-
pound heterozygosity for a mild and severe mutation
leads to postlingual hearing impairment. The intra-
familial variation indicates that these data do not allow
prediction of the phenotypic outcome for individual
cases. Analysis of more families is necessary to confirm
our conclusions and to address whether a subclassifica-
tion of the mutations associated with DFNB8 is possible.
Also, other (epi)genetic and nongenetic factors are
likely to influence the severity of the phenotype. This
has to be considered especially for families with a single
affected individual. For the families of this type in our
study, these factors did not seem to have a major effect
since the phenotype corresponded to the previously
reported phenotype of patients with the same mutations.
CONCLUSION
In patients with progressive hearing impairment and a
possible autosomal recessive mode of inheritance,
TMPRSS3 mutations should be considered. The ski-
slope audiogram configuration is suggestive for muta-
tions in this gene. The age of onset and the rate of
progression are variable. Our analyses suggest that
mutations in TMPRSS3 can probably be classified as
mild and severe mutations according to their pheno-
typic effect. Furthermore, our results demonstrate
that cochlear implantation is a good treatment option
for patients with TMPRSS3 mutations since satisfactory
speech reception was observed.
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